After a previous deal proposal for $48 per share was rejected by Versum’s (VSM) management, Merck KGaA (MKGAY) has made a full takeover offer to Versum shareholders for the same price, Reuters’ Ludwig Burger reports. In connection with the tender offer, Merck has fully committed financing from Bank of America Merrill Lynch (BAC), BNP Paribas Fortis (BNPQY) and Deutsche Bank (DB), according to the report.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.